Efficacy of fourth-line chemotherapy in advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of fourth-line chemotherapy in advanced non-small-cell lung cancer

Published:2015-09 Issue:8 Volume:26 Page:807-812
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Petrelli Fausto,Coinu Andrea,Cabiddu Mary,Borgonovo Karen,Ghilardi Mara,Lonati Veronica,Barni Sandro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference23 articles.

1. . Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.;Shepherd;J Clin Oncol,2000

2. . Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.;Hanna;J Clin Oncol,2004

3. . Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.;Shaw;N Engl J Med,2013

4. . Erlotinib in previously treated non-small-cell lung cancer.;Shepherd;N Engl J Med,2005

5. . Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy.;Imai;Med Oncol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perceptions and Knowledge Regarding Medical Situations at the End of Life among Older Adults in Switzerland;Journal of Palliative Medicine;2023-01-01

2. Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer;Cancer Treatment and Research Communications;2022

3. Guía de Práctica Clínica Nacional para el manejo del Cáncer de Pulmón de células no pequeñas en estadios tempranos, localmente avanzados y metastásicos;Salud Pública de México;2019-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3